Pfizer vaccine shows potential in early human trials; with minor side effects
Updated: 2020-07-02 08:43:55 KST
COVID-19 vaccine made by U.S. pharmaceutical giant Pfizer and German biotech firm BioNTech says their COVID-19 vaccine shows potential in early human trials, perhaps adding more breathing room to the COVID-19 vaccine business
The drug is one of 17 being tested on humans in a global race to find a vaccine that has touched over 10-and-a-half million people so far.
A relatively small trial, though, with 45 people and it still has yet to be peer-reviewed or published in a journal, but it showed that the drugs incited an immune response in healthy patients.
It also came with some side effects including fever at higher doses.
Another leading vaccine candidate from the industry, Moderna is expected to enter late-stage trial later this month.